• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

氨基乙酰丙酸经膀胱内给药至犬后的药代动力学。

Pharmacokinetics of aminolevulinic acid after intravesical administration to dogs.

作者信息

Dalton J T, Zhou D, Mukherjee A, Young D, Tolley E A, Golub A L, Meyer M C

机构信息

Department of Pharmaceutical Sciences, College of Pharmacy, University of Tennessee, Memphis 38163, USA.

出版信息

Pharm Res. 1999 Feb;16(2):288-95. doi: 10.1023/a:1018840827910.

DOI:10.1023/a:1018840827910
PMID:10100316
Abstract

PURPOSE

To examine the stability and systemic absorption of aminolevulinic acid (ALA) in dogs during intravesical administration.

METHODS

Nine dogs received an intravesical dose of ALA either with no prior treatment, after receiving ammonium chloride for urinary acidification, or after receiving sodium bicarbonate for urinary alkalinization. Urine and blood samples collected during and after administration were monitored for ALA using an HPLC assay developed in our laboratories. Concentrations of pyrazine 2,5-dipropionic acid, the major ALA degradation product, and radiolabeled inulin, a nonabsorbable marker for urine volume, were also determined.

RESULTS

Less than 0.6% of intravesical ALA doses was absorbed into plasma. Urine concentrations decreased to 37% of the initial concentration during the 2 hour instillation. Decreases in urinary ALA and radiolabeled inulin concentrations were significantly correlated, indicating that urine dilution accounted for over 80% of observed decreases in urinary ALA. ALA conversion to pyrazine 2,5-dipropionic acid was negligible.

CONCLUSIONS

These studies demonstrate that ALA is stable and poorly absorbed into the systemic circulation during intravesical instillation. Future studies utilizing intravesical ALA for photodiagnosis of bladder cancer should include measures to restrict fluid intake as a means to limit dilution and maximize ALA concentrations during instillation.

摘要

目的

研究氨基乙酰丙酸(ALA)在犬膀胱内给药期间的稳定性及全身吸收情况。

方法

9只犬分别在未进行预处理、接受氯化铵使尿液酸化或接受碳酸氢钠使尿液碱化后接受膀胱内给予的ALA剂量。使用我们实验室开发的高效液相色谱法(HPLC)测定给药期间及给药后采集的尿液和血液样本中的ALA。还测定了主要的ALA降解产物吡嗪2,5 - 二丙酸的浓度以及放射性标记的菊粉(一种尿液体积的不可吸收标记物)的浓度。

结果

膀胱内给予的ALA剂量中,吸收进入血浆的比例不到0.6%。在2小时滴注期间,尿液浓度降至初始浓度的37%。尿液中ALA和放射性标记菊粉浓度的降低显著相关,表明尿液稀释占观察到的尿液中ALA降低的80%以上。ALA转化为吡嗪2,5 - 二丙酸的量可忽略不计。

结论

这些研究表明,在膀胱内滴注期间,ALA是稳定的,且全身吸收较差。未来利用膀胱内给予ALA进行膀胱癌光诊断的研究应包括限制液体摄入的措施,以此作为在滴注期间限制稀释并使ALA浓度最大化的一种手段。

相似文献

1
Pharmacokinetics of aminolevulinic acid after intravesical administration to dogs.氨基乙酰丙酸经膀胱内给药至犬后的药代动力学。
Pharm Res. 1999 Feb;16(2):288-95. doi: 10.1023/a:1018840827910.
2
Clinical pharmacokinetics of 5-aminolevulinic acid in healthy volunteers and patients at high risk for recurrent bladder cancer.5-氨基酮戊酸在健康志愿者和复发性膀胱癌高危患者中的临床药代动力学
J Pharmacol Exp Ther. 2002 May;301(2):507-12. doi: 10.1124/jpet.301.2.507.
3
Pharmacokinetics of aminolevulinic acid after oral and intravenous administration in dogs.氨基乙酰丙酸在犬口服和静脉给药后的药代动力学
Drug Metab Dispos. 1999 Apr;27(4):432-5.
4
Biodistribution of protoporphyrin IX in rat urinary bladder after intravesical instillation of 5-aminolevulinic acid.膀胱内灌注5-氨基乙酰丙酸后原卟啉IX在大鼠膀胱中的生物分布。
J Urol. 1996 May;155(5):1744-8.
5
Intravesical administration of 5-aminolevulinic acid (5-ALA). Safety and pharmacokinetics of 5-ALA and its metabolite protoporphyrin IX.5-氨基酮戊酸(5-ALA)的膀胱内给药。5-ALA及其代谢产物原卟啉IX的安全性和药代动力学。
Eur J Clin Pharmacol. 2000 Jun;56(3):241-6. doi: 10.1007/s002280000151.
6
The fluorescence biodistribution and kinetics of aminolevulinic acid induced protoporphyrin IX in the bladder of a rat model with orthotopic urothelial carcinoma.原位尿路上皮癌大鼠模型膀胱中氨基乙酰丙酸诱导的原卟啉IX的荧光生物分布及动力学
J Urol. 2002 Apr;167(4):1848-53.
7
Determination of the bioavailability of [14C]-hexaminolevulinate using accelerator mass spectrometry after intravesical administration to human volunteers.膀胱内给药于人类志愿者后,使用加速器质谱法测定[14C] - 六氨基乙酰丙酸的生物利用度。
J Clin Pharmacol. 2006 Apr;46(4):456-60. doi: 10.1177/0091270006286849.
8
No generalized skin phototoxicity after intravesical application of 5-aminolevulinic acid for fluorescence diagnosis of superficial bladder cancer.膀胱内应用5-氨基酮戊酸进行浅表性膀胱癌荧光诊断后未出现全身性皮肤光毒性。
Urol Int. 2000;64(3):126-8. doi: 10.1159/000030511.
9
Degradation mechanism and stability of 5-aminolevulinic acid.5-氨基乙酰丙酸的降解机制与稳定性
J Pharm Sci. 2000 Oct;89(10):1335-41. doi: 10.1002/1520-6017(200010)89:10<1335::aid-jps11>3.0.co;2-#.
10
An open pharmacokinetic study of hexylaminolevulinate-induced photodiagnosis after intravesical administration.膀胱内给药后六氨基乙酰丙酸诱导光诊断的开放性药代动力学研究。
Drugs R D. 2006;7(3):173-86. doi: 10.2165/00126839-200607030-00005.

本文引用的文献

1
Photodynamic therapy (PDT) and photodiagnosis (PD) using endogenous photosensitization induced by 5-aminolevulinic acid (ALA): current clinical and development status.使用5-氨基酮戊酸(ALA)诱导内源性光敏化的光动力疗法(PDT)和光诊断(PD):当前临床及发展状况。
J Clin Laser Med Surg. 1996 Apr;14(2):59-66. doi: 10.1089/clm.1996.14.59.
2
Chemical instability of 5-aminolevulinic acid used in the fluorescence diagnosis of bladder tumours.用于膀胱肿瘤荧光诊断的5-氨基乙酰丙酸的化学不稳定性。
J Photochem Photobiol B. 1996 Jul;34(2-3):143-8. doi: 10.1016/1011-1344(96)07285-5.
3
Endogenous porphyrin distribution induced by 5-aminolaevulinic acid in the tissue layers of the gastrointestinal tract.
5-氨基乙酰丙酸诱导的内源性卟啉在胃肠道各组织层中的分布
J Photochem Photobiol B. 1993 Sep;20(1):47-54. doi: 10.1016/1011-1344(93)80130-2.
4
Fluorescence photodetection of neoplastic urothelial lesions following intravesical instillation of 5-aminolevulinic acid.膀胱内灌注5-氨基酮戊酸后对肿瘤性尿路上皮病变进行荧光光检测。
Urology. 1994 Dec;44(6):836-41. doi: 10.1016/s0090-4295(94)80167-3.
5
Detection of early bladder cancer by 5-aminolevulinic acid induced porphyrin fluorescence.通过5-氨基乙酰丙酸诱导的卟啉荧光检测早期膀胱癌
J Urol. 1996 Jan;155(1):105-9; discussion 109-10.
6
Stability of delta-aminolevulinic acid and porphobilinogen in urine under varying conditions.不同条件下尿液中δ-氨基乙酰丙酸和胆色素原的稳定性
Clin Chem. 1968 Jul;14(7):610-4.
7
The preservation of urine specimens for delta-aminolevulinic acid determination.用于测定δ-氨基乙酰丙酸的尿液标本保存。
Clin Chem. 1970 Jul;16(7):612-3.
8
Evidence of significant absorption of sodium salicylate from urinary bladder of rats.大鼠膀胱对水杨酸钠有显著吸收的证据。
J Pharmacol Exp Ther. 1991 Jul 1;258(1):357-64.
9
Pharmacokinetics of intravesical mitomycin C in superficial bladder cancer patients.表浅膀胱癌患者膀胱内注射丝裂霉素C的药代动力学
Cancer Res. 1991 Oct 1;51(19):5144-52.
10
A method to study drug concentration-depth profiles in tissues: mitomycin C in dog bladder wall.一种研究组织中药物浓度-深度分布的方法:犬膀胱壁中的丝裂霉素C。
Pharm Res. 1991 Feb;8(2):168-73. doi: 10.1023/a:1015827700904.